| Q51824317 | Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease. |
| Q36299346 | Blisters and Loss of Epidermis in Patients With Lupus Erythematosus: A Clinicopathological Study of 22 Patients |
| Q53746240 | Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. |
| Q89583997 | Clinicopathological and Immunological Profile of Patients with Cutaneous Manifestations and their Relationship with Organ Involvement in Systemic Lupus Erythematosus Attending a Tertiary Care Center of Eastern India |
| Q38627179 | Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus--a systematic review |
| Q41534109 | Current concepts and advances in clinical laboratory testing for autoimmune diseases |
| Q37608166 | Cutaneous lupus erythematosus: An update |
| Q37930698 | Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus |
| Q22299248 | Epidemiology and socioeconomic impact of skin disease in lupus erythematosus |
| Q51541832 | Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI. |
| Q37038484 | Pathophysiology of cutaneous lupus erythematosus |
| Q40506590 | Prognosis in systemic lupus erythematosus |
| Q35564640 | Skin lesions in lupus erythematosus: a marker of systemic involvement |
| Q37778654 | The impact of the EUSCLE core set questionnaire for the assessment of cutaneous lupus erythematosus |